Anti-Obesity Effect of Dyglomera® Is Associated with Activation of the AMPK Signaling Pathway in 3T3-L1 Adipocytes and Mice with High-Fat Diet-Induced Obesity

Molecules. 2022 May 20;27(10):3288. doi: 10.3390/molecules27103288.

Abstract

Dyglomera® is an aqueous ethanol extract of the fruit pods of Dichrostachys glomerata, a Cameroonian spice. Several studies have shown its anti-diabetic and anti-obesity effects. However, the underlying mechanisms for such effects remain unclear. Thus, the objective of this study was to investigate the anti-obesity effect of Dyglomera® and its underlying mechanisms in mice with high-fat diet-induced obesity and 3T3-L1 adipocytes. Our results revealed that Dyglomera® inhibited adipogenesis and lipogenesis by regulating AMPK phosphorylation in white adipose tissues (WATs) and 3T3-L1 adipocytes and promoted lipolysis by increasing the expression of lipolysis-related proteins. These results suggest that Dyglomera® can be used as an effective dietary supplement for treating obesity due to its modulating effect on adipogenesis/lipogenesis and lipolysis.

Keywords: 3T3-L1 adipocytes; Dichrostachys glomerata extract; Dyglomera®; adipogenesis; anti-obesity; high-fat diet-induced obesity; lipogenesis; lipolysis.

MeSH terms

  • 3T3-L1 Cells
  • AMP-Activated Protein Kinases* / metabolism
  • Adipocytes
  • Animals
  • Diet, High-Fat* / adverse effects
  • Mice
  • Mice, Inbred C57BL
  • Obesity / drug therapy
  • Obesity / etiology
  • Obesity / metabolism
  • Signal Transduction

Substances

  • AMP-Activated Protein Kinases

Grants and funding

This research received no external funding.